Mannkind (MNKD) Capital Expenditures Growth (3y) (2013 - 2026)
Mannkind (MNKD) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -68.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.21% |
| Dec 31, 2025 | -15.13% |
| Sep 30, 2025 | -47.41% |
| Jun 30, 2025 | 27.97% |
| Mar 31, 2025 | -4.84% |
| Dec 31, 2024 | -44.19% |
| Sep 30, 2024 | 27.64% |
| Jun 30, 2024 | -43.39% |
| Mar 31, 2024 | 168.79% |
| Dec 31, 2023 | -53.37% |
| Sep 30, 2023 | 440.61% |
| Jun 30, 2023 | -255.74% |
| Mar 31, 2023 | 281.23% |
| Dec 31, 2022 | -47.95% |
| Sep 30, 2022 | -32.30% |
| Jun 30, 2022 | -0.68% |
| Mar 31, 2022 | 15.90% |
| Mar 31, 2019 | -40.09% |
| Mar 31, 2016 | -7.79% |
| Dec 31, 2015 | 69.40% |